AU2002360025A1 - Famotidine injection - Google Patents

Famotidine injection

Info

Publication number
AU2002360025A1
AU2002360025A1 AU2002360025A AU2002360025A AU2002360025A1 AU 2002360025 A1 AU2002360025 A1 AU 2002360025A1 AU 2002360025 A AU2002360025 A AU 2002360025A AU 2002360025 A AU2002360025 A AU 2002360025A AU 2002360025 A1 AU2002360025 A1 AU 2002360025A1
Authority
AU
Australia
Prior art keywords
famotidine injection
famotidine
injection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002360025A
Inventor
Tomoyuki Hojo
Shigeru Suzuki
Satoko Tabata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Publication of AU2002360025A1 publication Critical patent/AU2002360025A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2002360025A 2001-12-27 2002-12-25 Famotidine injection Abandoned AU2002360025A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001/396030 2001-12-27
JP2001396030 2001-12-27
PCT/JP2002/013530 WO2003055483A1 (en) 2001-12-27 2002-12-25 Famotidine injection

Publications (1)

Publication Number Publication Date
AU2002360025A1 true AU2002360025A1 (en) 2003-07-15

Family

ID=19189046

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002360025A Abandoned AU2002360025A1 (en) 2001-12-27 2002-12-25 Famotidine injection

Country Status (3)

Country Link
JP (1) JP4374250B2 (en)
AU (1) AU2002360025A1 (en)
WO (1) WO2003055483A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4926391B2 (en) * 2004-09-30 2012-05-09 テルモ株式会社 Method for producing hemoglobin-containing liposome and package
JP4598484B2 (en) * 2004-11-11 2010-12-15 テルモ株式会社 Ritodrine hydrochloride injection solution
JP2006271748A (en) * 2005-03-30 2006-10-12 Taiyo Yakuhin Kogyo Kk Package protecting injection solution from deterioration

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58103312A (en) * 1981-12-15 1983-06-20 Yamanouchi Pharmaceut Co Ltd Aqueous solution for injection of hardly soluble drug and its preparation
GB8313217D0 (en) * 1983-05-13 1983-06-22 Glaxo Group Ltd Pharmaceutical compositions
JPH0564653A (en) * 1991-06-26 1993-03-19 Terumo Corp Packing body for transfusion agent
US5169864A (en) * 1991-11-15 1992-12-08 Baxter International Inc. Unbuffered premixed ranitidine formulation
US5650421A (en) * 1995-03-31 1997-07-22 Baxter International Inc. Premixed famotidine formulation
JP4120848B2 (en) * 1997-05-14 2008-07-16 東洋紡績株式会社 Hemostasis or tissue adhesive for living body

Also Published As

Publication number Publication date
JPWO2003055483A1 (en) 2005-04-28
JP4374250B2 (en) 2009-12-02
WO2003055483A1 (en) 2003-07-10

Similar Documents

Publication Publication Date Title
AU2002359919A1 (en) Syringe
AU2002253039A1 (en) Tramadol-based medicament
AU2002361092A1 (en) Syringe
AU2002360025A1 (en) Famotidine injection
AU2002349142A1 (en) Syringe
AU2002257551A1 (en) Injection device
AU2002226571A1 (en) Biligands
AU2001100406A4 (en) DriverSMS
AU2002245337A1 (en) Epoxyvibsanin b
AU2002216382A1 (en) Famotidine injections
AUPR675001A0 (en) Cryoprotection
AUPR955201A0 (en) Injector
AU2002255331A1 (en) Injector
AU2002257925A1 (en) Numberplates
AU2002238350A1 (en) Infusion set
AU2002100746A4 (en) Adrail
AU2001100214A4 (en) Dolly-trolley
AU2001100532A4 (en) FonePark
AU2001100522A4 (en) e-Trans
AU2001100338A4 (en) Sunglove
AUPR325301A0 (en) Easy build - mpt - system
AU2002302458A1 (en) Paint-can with bruswiper
AU2002322343A1 (en) Improved inductrack configuration
AU2001298048A1 (en) **
AU2002362548A1 (en) **

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase